Search

everythinglearnresearchcommunity

for

Search:↓

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

CRABP2 helps increase the growth of cells important for hair growth by activating a specific growth pathway.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

Erlotinib can cause nonscarring hair loss and itchy skin.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.

Meis1 is crucial for skin health and tumor development.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Loss of TET2 increases the risk of skin and oral cancer.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

A Korean baby with nevus sebaceus syndrome was found to have a KRAS gene mutation.

WYE-130600 may cause skin thickening and irritation.

Neuropilin 2 may be a biomarker for melanoma and affects melanocyte behavior.

A specific gene mutation in KRT86 is linked to hair disorder in a Chinese Han family.

Mutant stem cells adapt their metabolism differently to outcompete normal cells in the skin.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.